Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 20;175(1):239-253.e17.
doi: 10.1016/j.cell.2018.08.019. Epub 2018 Sep 6.

Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs

Affiliations
Free article

Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs

Katrina Meyer et al. Cell. .
Free article

Abstract

Many disease-causing missense mutations affect intrinsically disordered regions (IDRs) of proteins, but the molecular mechanism of their pathogenicity is enigmatic. Here, we employ a peptide-based proteomic screen to investigate the impact of mutations in IDRs on protein-protein interactions. We find that mutations in disordered cytosolic regions of three transmembrane proteins (GLUT1, ITPR1, and CACNA1H) lead to an increased clathrin binding. All three mutations create dileucine motifs known to mediate clathrin-dependent trafficking. Follow-up experiments on GLUT1 (SLC2A1), the glucose transporter causative of GLUT1 deficiency syndrome, revealed that the mutated protein mislocalizes to intracellular compartments. Mutant GLUT1 interacts with adaptor proteins (APs) in vitro, and knocking down AP-2 reverts the cellular mislocalization and restores glucose transport. A systematic analysis of other known disease-causing variants revealed a significant and specific overrepresentation of gained dileucine motifs in structurally disordered cytosolic domains of transmembrane proteins. Thus, several mutations in disordered regions appear to cause "dileucineopathies."

Keywords: Glut1 deficiency syndrome; dileucine motif; endocytic trafficking; epilepsy; intrinsic disorder; mass spectrometry; point mutation; protein-protein interaction; proteomics.

PubMed Disclaimer

Comment in

Publication types

MeSH terms

Supplementary concepts